These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 10800165

  • 1. Diagnosis of essential thrombocythemia at platelet counts between 400 and 600x10(9)/L. Gruppo Italiano Malattie Mieloproliferative Croniche(GIMMC).
    Sacchi S, Vinci G, Gugliotta L, Rupoli S, Gargantini L, Martinelli V, Baravelli S, Lazzarino M, Finazzi G.
    Haematologica; 2000 May; 85(5):492-5. PubMed ID: 10800165
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Essential thrombocythemia: a 35-year experience and review of the literature].
    Majluf Cruz A, Mijangos Huesca J, Sosa Camas RE, Gómez Fuentes G, Bolaños Ulloa F, Labardini Méndez J.
    Rev Invest Clin; 1994 May; 46(5):383-92. PubMed ID: 7839019
    [Abstract] [Full Text] [Related]

  • 4. Splenectomy after portal thrombosis in patients with polycythemia vera and essential thrombocythemia.
    Randi ML, Fabris F, Ruzzon E, Pacquola E, Cella G, Girolami A.
    Haematologica; 2002 Nov; 87(11):1180-4. PubMed ID: 12414348
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term follow-up of 386 consecutive patients with essential thrombocythemia: safety of cytoreductive therapy.
    Palandri F, Catani L, Testoni N, Ottaviani E, Polverelli N, Fiacchini M, De Vivo A, Salmi F, Lucchesi A, Baccarani M, Vianelli N.
    Am J Hematol; 2009 Apr; 84(4):215-20. PubMed ID: 19208420
    [Abstract] [Full Text] [Related]

  • 9. Essential thrombocythemia: a relative benign long-term course.
    Meisel S, Shpilberg O, Ramot B, Ben-Bassat I.
    Isr J Med Sci; 1993 Apr; 29(4):190-4. PubMed ID: 8491569
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders.
    Passamonti F, Vanelli L, Malabarba L, Rumi E, Pungolino E, Malcovati L, Pascutto C, Morra E, Lazzarino M, Cazzola M.
    Haematologica; 2003 Oct; 88(10):1123-9. PubMed ID: 14555308
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Thrombotic complications in essential thrombocythemia (ET): clinical facts and biochemical riddles.
    Petrides PE, Siegel F.
    Blood Cells Mol Dis; 2006 Oct; 36(3):379-84. PubMed ID: 16563815
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Thrombocytosis and thrombocythemia.
    Mitus AJ, Schafer AI.
    Hematol Oncol Clin North Am; 1990 Feb; 4(1):157-78. PubMed ID: 2155903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.